日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cancer statistics, 2026: Charting a course for a national cancer research agenda

2026年癌症统计数据:为国家癌症研究议程制定路线图

Lara, Primo N Jr; Hershman, Dawn L

Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216

转移性激素敏感性前列腺癌患者体重指数与总生存期的相关性:SWOG-1216患者个体数据分析

Swami, Umang; Jo, Yeonjung; Narang, Arshit; Plets, Melissa; Hage Chehade, Chadi; Gebrael, Georges; Gupta, Shilpa; Myint, Zin; Tangen, Catherine; Lara, Primo N Jr; Thompson, Ian M Jr; Hussain, Maha H A; Dorff, Tanya B; Lerner, Seth P; Agarwal, Neeraj

A Phase 1/1B Trial of Pembrolizumab and Trametinib in Advanced NSCLC Enriched for KRAS Mutations.

帕博利珠单抗和曲美替尼治疗富含 KRAS 突变的晚期非小细胞肺癌的 1/1B 期试验

Riess Jonathan W, Lara Matthew S, Luxardi Guillaume, Lopez de Rodas Miguel, Shimoda Michiko, Kelly Karen, Lara Primo N, Beckett Laurel, Monjazeb Arta, Schalper Kurt A, Maverakis Emanual, Gandara David R

POLE Mutation Associated With Microsatellite Instability and High Tumor Mutational Burden Confers Exquisite Sensitivity to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer: A Case Report and Genomic Database Analysis

POLE基因突变与微卫星不稳定性及高肿瘤突变负荷相关,赋予非小细胞肺癌对免疫检查点抑制剂治疗的极高敏感性:病例报告及基因组数据库分析

Lara, Matthew S; Riess, Jonathan W; Kaleka, Guneet; Borowsky, Alexander; McPherson, John D; Godoy, Luis A; Grego, Lorenzo; Lara, Primo N Jr; Mitsiades, Nicholas

Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors

卡博替尼和纳武利尤单抗单药或联合伊匹木单抗治疗晚期/转移性泌尿生殖系统肿瘤的I期试验及扩展队列的最终结果

Apolo, Andrea B; Girardi, Daniel M; Niglio, Scot A; Nadal, Rosa; Kydd, Andre R; Simon, Nicholas; Ley, Lisa; Cordes, Lisa M; Chandran, Elias; Steinberg, Seth M; Lee, Sunmin; Lee, Min-Jung; Rastogi, Shraddha; Sato, Nahoko; Cao, Liang; Banday, A Rouf; Boudjadi, Salah; Merino, Maria J; Toubaji, Antoun; Akbulut, Dilara; Redd, Bernadette; Bagheri, Hadi; Costello, Rene; Gurram, Sandeep; Agarwal, Piyush K; Chalfin, Heather J; Valera, Vladimir; Streicher, Howard; Wright, John Joseph; Sharon, Elad; Figg, William D; Parnes, Howard L; Gulley, James L; Saraiya, Biren; Pal, Sumanta K; Quinn, David; Stein, Mark N; Lara, Primo N; Bottaro, Donald P; Mortazavi, Amir

Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma

S1500研究的最终总生存期分析:一项比较舒尼替尼与卡博替尼、克唑替尼和沙伐替尼治疗晚期乳头状肾细胞癌的随机II期研究

Barata, Pedro; Tangen, Catherine; Plets, Melissa; Thompson, Ian M Jr; Narayan, Vivek; George, Daniel J; Heng, Daniel Y C; Shuch, Brian; Stein, Mark; Gulati, Shuchi; Tretiakova, Maria; Tripathi, Abhishek; Bjarnason, Georg A; Humphrey, Peter; Adeniran, Adebowale; Vaishampayan, Ulka; Alva, Ajjai; Zhang, Tian; Cole, Scott; Lara, Primo N Jr; Lerner, Seth P; Balzer-Haas, Naomi; Pal, Sumanta K

Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study

肾细胞癌患者行肾切除术期间围手术期使用纳武利尤单抗与观察的比较(PROSPER ECOG-ACRIN EA8143):一项开放标签、随机、3期研究

Allaf, Mohamad E; Kim, Se-Eun; Master, Viraj; McDermott, David F; Harshman, Lauren C; Cole, Suzanne M; Drake, Charles G; Signoretti, Sabina; Akgul, Mahmut; Baniak, Nicholas; Li-Ning, Elsa; Palmer, Matthew B; Emamekhoo, Hamid; Adra, Nabil; Kaimakliotis, Hristos; Ged, Yasser; Pierorazio, Phillip M; Abel, E Jason; Bilen, Mehmet A; Ogan, Kenneth; Moon, Helen H; Ramaswamy, Krishna A; Singer, Eric A; Mayer, Tina M; Lohrey, Jay; Margulis, Vitaly; Gills, Jessie; Delacroix, Scott E; Waples, Mark J; James, Andrew C; Wang, Peng; Choueiri, Toni; Michaelson, M Dror; Kapoor, Anil; Heng, Daniel Y; Shuch, Brian; Leibovich, Bradley C; Lara, Primo N; Manola, Judith; Maskens, Deborah; Battle, Dena; Uzzo, Robert; Bratslavsky, Gennady; Haas, Naomi B; Carducci, Michael A

Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial

转移性激素敏感性前列腺癌患者的骨痛与生存率:SWOG-1216试验的二次分析

Gebrael, Georges; Jo, Yeonjung; Swami, Umang; Plets, Melissa; Hage Chehade, Chadi; Narang, Arshit; Gupta, Shilpa; Myint, Zin W; Sayegh, Nicolas; Tangen, Catherine M; Hussain, Maha; Dorff, Tanya; Lara, Primo N Jr; Lerner, Seth P; Thompson, Ian; Agarwal, Neeraj

Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial

依维莫司辅助治疗非透明细胞肾细胞癌:一项随机临床试验的二次分析

Gulati, Shuchi; Tangen, Catherine; Ryan, Christopher W; Vaishampayan, Ulka N; Shuch, Brian M; Barata, Pedro C; Pruthi, Deepak K; Bergerot, Cristiane D; Tripathi, Abhishek; Lerner, Seth P; Thompson, Ian M Jr; Lara, Primo N Jr; Pal, Sumanta K

Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer

循环肿瘤细胞计数与转移性激素敏感性前列腺癌患者的总生存期

Goldkorn, Amir; Tangen, Catherine; Plets, Melissa; Bsteh, Daniel; Xu, Tong; Pinski, Jacek K; Ingles, Sue; Triche, Timothy Junius; MacVicar, Gary R; Vaena, Daniel A; Crispino, Anthony W; McConkey, David James; Lara, Primo N Jr; Hussain, Maha H A; Quinn, David I; Dorff, Tanya B; Lerner, Seth Paul; Thompson, Ian Jr; Agarwal, Neeraj